Shares of hospital operator Tenet Healthcare (NYSE:THC)
jumped 12.2% in the afternoon session after the company reported first-quarter 2025 results, which blew past analysts' EPS expectations on a solid revenue beat. Even though total revenue dipped a bit, that was mostly from selling off some hospitals.
Looking ahead, Tenet raised its full-year adjusted EPS guidance, while keeping its revenue outlook unchanged, signaling confidence in margin expansion even without top-line acceleration. Overall, this quarter was still solid.
Hospital operator Tenet Healthcare (NYSE:THC) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 2.7% year on year to $5.22 billion. The company expects the full year’s revenue to be around $20.8 billion, close to analysts’ estimates. Its non-GAAP profit of $4.36 per share was 39.2% above analysts’ consensus estimates.
The Wall Street Journal highlighted UHS, THC and HCA as key beneficiaries of Medicaid supplemental payment programs that cost the federal government hundreds of billions.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how hospital chains stocks fared in Q4, starting with Acadia Healthcare (NASDAQ:ACHC).
Shareholders of Tenet Healthcare would probably like to forget the past six months even happened. The stock dropped 20.1% and now trades at $124. This might have investors contemplating their next move.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how hospital chains stocks fared in Q4, starting with Tenet Healthcare (NYSE:THC).
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at HCA Healthcare (NYSE:HCA) and its peers.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the hospital chains industry, including Universal Health Services (NYSE:UHS) and its peers.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,
and over the past six months, the industry has pulled back by 11.2%. This drawdown was much worse than the S&P 500’s 1.1% decline.
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.
However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
Hospital operator Tenet Healthcare (NYSE:THC) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 5.7% year on year to $5.07 billion. The company’s full-year revenue guidance of $20.8 billion at the midpoint came in 2.4% below analysts’ estimates. Its non-GAAP profit of $3.44 per share was 21.5% above analysts’ consensus estimates.
On Tuesday January 28, 2025, a federal health payment system lockout, blamed on an "outage," sparked criticism amid Trump's spending freeze, though payments were reportedly unaffected, according to the white house.
